AstraZeneca and Daiichi Sankyo win new EU approval for breast cancer drug
AstraZeneca and Daiichi Sankyo received a new EU approval for a breast cancer drug.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.